Efrem Hagos Gebremedhin, M.D
Endocrinology, Diabetes & Metabolism Physician · Folsom, CA
Efrem Hagos Gebremedhin, M.D is an endocrinology, diabetes & metabolism physician with a practice address in Folsom, California, and NPI 1649458803, issued on Feb 9, 2008. Check the license (California A100766, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Efrem Hagos Gebremedhin
- Credential
- M.D
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License numbers
- A100766 CA
04-34460 KS
Self-reported in NPPES; status is on the state search - Practice location
- 1730 Prairie City RD Ste 120, Folsom, CA 95630
- Phone
- (916) 351-4800
- Enumerated
- Feb 9, 2008
- Record last updated
- Mar 1, 2021 (not updated in 5 years: call before relying on the address or phone)
- Fax
- (916) 357-6194
- Medicare enrollment
- Enrolled (PECOS I20090909000621); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 1730 Prairie City RD Ste 120
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Rohit Bhaskar, MDCardiovascular Disease Physician1467524520
- Melissa Formica, NPAcute Care Nurse Practitioner1679299382
- Max Haffner, MDOrthopaedic Surgery Physician1700323425
- Zachary Hoffman, PA-CPhysician Assistant1982487021
- Myron Jimenez, O.D.Optometrist1174076681
- Roy Kaku, MDCardiovascular Disease Physician1467524546
Verify Efrem Hagos Gebremedhin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A100766Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
99% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
5,226 Medicare Part D claims for 656 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 53% of claims.
Most prescribed
- Levothyroxine Sodium714 claims
- Ozempic632 claims
- Mounjaro293 claims
- Metformin Hcl182 claims
- Jardiance180 claims
- Lantus Solostar166 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 96.5 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $24.26
1 payment: education; the largest payer was Amgen Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Dignity Health Medical FoundationFolsom, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in California
There are 1,131 endocrinology, diabetes & metabolism physician records in California.
Other endocrinology, diabetes & metabolism physician records in California
- Evan Abel, MDSanta Monica, CA1619067238
- Anita Abraham, M.D.Stockton, CA1558380337
- Sallie Adams, M.D.Roseville, CA1255342085
- Helen Adelberg, M.D.Encino, CA1093935447
- Yewande Adepoju, DOOroville, CA1467892984
- David Aftergood, MDBeverly Hills, CA1639259328
- Nidhi Agarwal, MDTorrance, CA1518387125
- Bahar Aghighi, MDSanta Cruz, CA1770562134
- Tyler Aguinaldo, MDBurlingame, CA1306811906
- Susan Ahern, D.O.Ventura, CA1508156597
Common questions
What is Efrem Hagos Gebremedhin, M.D's NPI number?
Efrem Hagos Gebremedhin, M.D's National Provider Identifier (NPI) is 1649458803, issued on Feb 9, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Efrem Hagos Gebremedhin, M.D located?
The NPPES record lists a practice address at 1730 Prairie City RD Ste 120, Folsom, CA, 95630. Phone: (916) 351-4800. Providers update this record themselves, so call before visiting.
How can I verify Efrem Hagos Gebremedhin, M.D's license?
NPPES lists California license number A100766, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Efrem Hagos Gebremedhin, M.D prescribe under Medicare Part D?
In 2024, Efrem Hagos Gebremedhin, M.D had 5,226 Medicare Part D claims for 656 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
What is Efrem Hagos Gebremedhin, M.D's MIPS final score?
The 2023 MIPS final score is 96.5 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.